• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Events
  • Education
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

💊Polypharmacy focus for Yellow Card campaign

19th February 2020 by PIP editor Leave a Comment

 

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a week-long social media campaign to raise awareness about the importance of reporting suspected side effects using the Yellow Card Scheme.

 

The week will focus on polypharmacy: reporting side effects helps ensure safe use when taking multiple medicines.

 

Healthcare professionals are also being encouraged to review their patients’ medications intake, especially when prescribing, dispensing and administrating multiple medicines, as well as being vigilant to monitor, detect and report suspected side effects to the Yellow Card Scheme. Reporting plays an important role in helping MHRA monitor the safe use of medicines to protect public health through effective regulation.

 

Mick Foy, Head of Pharmacovigilance Strategy, at the MHRA says:

 

“Protecting patients is our topmost priority. Patients, their carers, and healthcare professionals are asked to report suspected side effects on a Yellow Card to the MHRA online or via the app.

 

“Reporting helps to improve the safety of medicines for all patients and can result in better tailored prescribing or administrative advice and information about monitoring, which can help improve adherence to treatment, and ultimately improves patient safety.”

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  £5million invested in community pharmacy delivery service

Filed Under: News Tagged With: PIP news

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

Why is a decision on the pre-reg exam problem taking so long?

Is there a pragmatic way through the provisional registration problem?

Excessive accumulation of medication at home is common

Resitters: The forgotten pre-registration pharmacist cohort

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.